The Taylor Smith and Victor Curtin Lectures
Records per page:
2024David S. Boyer, MDCentral Serous Retinopathy: Past, Present, and Future
2023Giovanni Staurenghi, MDHigh Resolution OCT: What We Miss
2022Timothy G. Murray, MD, MBAAdvances in Ocular Oncology - Three Decades Define Patient Care
2021Robert L. Avery, MDAnti-VEGF for Retinal Disease: An Interesting Journey, And Where We Are Headed
2020Carol L. Shields, MDIntraocular Tumors - A Footprint into the Future
2019Yale L. Fisher, MDThe Essence of Diagnostic Ultrasonography
2018Daniel F. Martin, MDIntravitreal Therapy for Retinal Diseases: From CMV to CNV
2017Gary W. Abrams, MDOptogenic Vision Resoration
2016Neil M. Bressler, MDImpact of Recent DRCR.net Randomized Clinical Trial Results on Managing Diabetic Retinopathy in 2016
2015George A. Williams, MDHealth Care Reform 2015
2014Julia A. Haller, MDNothing in Vein: The Evolution of Management of Retinal Vein Occlusions
2013Michael T. Trese, MDVitreous Relationships to Retinal Disease and Enzymatic Manipulation
2012J. Brooks Crawford, MDIs Ocular Pathology Still Relevant to Clinical Ophthalmology?
2011David W. Parke, II, MDThe Practice Environment of Retina in 2015: What’s the Prognosis?
2010Carmen A. Puliafito, MD, MBAOptical Coherence Tomography at the Brink: Intraoperative Imaging and Navigation and Multimodal Applications
2009Alexander R. Gaudio, MDERG — A Panegyric
2008Allan E. Kreiger, MDScleral Buckling for Retinal Detachment
2007Mark S. Blumenkranz, MDEvolving Concepts of Retinal Photocoagulation
2006Jerry A. Shields, MDPseudomelanomas of Choroid and Ciliary Body
2005Thaddeus P. Dryja, MDBradyopsia and Other Newly Recognized Forms of Retinal Dysfunction
2004Steven T. Charles, MDAdvances in Vitreoretinal Instrumentation and Techniques
2003Evangelos S. Gragoudas, MDCurrent Management of Uveal Melanomas
2002William S. Tasman, MDRetinopathy of Prematurity: Past, Present and Future
2001Thomas R. Friberg, MDLeading Edge Technologies and Their Application to Vitreoretinal Practice
2000Ian J. Constable, MDInnovative Therapies for Vitreoretinal Diseases: Current Research and Clinical Trials
1 2 NEXT